Clinical Trial Update: Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma

View source ↗

Summary

A clinical trial update on Daratumumab-Pomalidomide-Dexamethasone (Dara-PD) for patients with first-relapse multiple myeloma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: FengYan Jin | Conditions: Multiple Myeloma, First Relapse | Status: RECRUITING